ReviewInternational journal of clinical oncology2022

Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs.

Hidekatsu Nakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.